MODIFIZIERTE RNAI-MITTEL

European patent · EP2880162 · In force

Register entry

Publication number
EP2880162
Application number
EP13747932
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 2, 2013
Published
Jun 10, 2015
Granted
Jul 5, 2017
Protection ends at the latest
Aug 1, 2033
Next annual fee due
Aug 31, 2027
IPC classes
C12N 15/113 (2010.01)
C12N 15/11 (2006.01)
C07H 21/02 (2006.01)
Priority
US 201261679396 P 03.08.2012
US 201361791750 P 15.03.2013
PCT application
PCT/US2013/053346 02.08.2013
PCT publication
WO2014/022739 06.02.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. Sep 6, 2022

    Change

    Published in Swissreg on 06.09.2022

  6. Jul 5, 2017

    Granted

    Published in Swissreg on 05.07.2017

Parties

Holder

Alnylam Pharmaceuticals, Inc.

300 Third Street, 3rd Floor, Cambridge, MA 02142, US

Inventor

RAJEEV, Kallanthottathil, G.

Cambridge, MA 02142, US

MANOHANRAN, Muthiah

Cambridge, MA 02142, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.